Internal Medicine, Rheumatology · Springfield, MA
NPI
1548257496
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3377 Main St
Springfield, MA, 01107
Phone (413) 734-5661
Groups this clinician bills Medicare through
Medicare paid, 2024
$844K
72,563 services
Medicare patients, 2024
783
Average age 75
Drug cost, 2024
$6.8M
7,104 prescriptions
Company payments, 2024
$44.81
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Scott M Halista was code J0897 (injection, denosumab, 1 mg), 4,860 times for 48 patients. In total Scott M Halista billed 72,563 services in 107 codes, and Medicare paid $844K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-01-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 4,860 | 48 | $20.54 | $100K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 4,320 | 14 | $24.84 | $107K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2,457 | 160 | $0.73 | $1,800 |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,689 | 51 | $0.10 | $163 |
| 36415 Venipuncture Blood Collection | Office | 1,152 | 573 | $8.65 | $9,965 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,051 | 598 | $12.11 | $13K |
| 82565 Clinical Chemistry | Office | 1,011 | 531 | $5.00 | $5,055 |
| 85025 Blood Count | Office | 937 | 467 | $7.59 | $7,108 |
| 84460 Clinical Chemistry | Office | 934 | 476 | $5.17 | $4,827 |
| 84450 Clinical Chemistry | Office | 932 | 475 | $5.06 | $4,719 |
| 99214 Office E&M - Established | Office | 890 | 535 | $92.10 | $82K |
| 85652 Clinical Chemistry | Office | 791 | 355 | $2.64 | $2,088 |
| 86140 Clinical Chemistry | Office | 752 | 332 | $5.05 | $3,800 |
| 99213 Office E&M - Established | Office | 562 | 328 | $65.96 | $37K |
| 82040 Clinical Chemistry | Office | 419 | 166 | $4.82 | $2,018 |
By year: 2022 $787K for 68,464 services; 2023 $846K for 76,216 services; 2024 $844K for 72,563 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,152 | 573 | $8.65 | $9,965 |
| 82565 Clinical Chemistry | 1,011 | 531 | $5.00 | $5,055 |
| 85025 Blood Count | 937 | 467 | $7.59 | $7,108 |
| 84460 Clinical Chemistry | 934 | 476 | $5.17 | $4,827 |
| 84450 Clinical Chemistry | 932 | 475 | $5.06 | $4,719 |
| 85652 Clinical Chemistry | 791 | 355 | $2.64 | $2,088 |
| 86140 Clinical Chemistry | 752 | 332 | $5.05 | $3,800 |
| 82040 Clinical Chemistry | 419 | 166 | $4.82 | $2,018 |
| 82306 Clinical Chemistry | 172 | 131 | $28.85 | $4,962 |
| 82310 Clinical Chemistry | 171 | 132 | $5.06 | $865 |
Medicare prescription drug claims, 2024
In 2024, the drug Scott M Halista prescribed most often to Medicare patients was Celecoxib, with 1,225 prescriptions and refills. In total Scott M Halista wrote 7,104 Medicare prescriptions that cost $6.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Celecoxib Generic | 1,225 | 1,873 | 271 | $32K |
| Methotrexate Methotrexate Sodium | 1,042 | 1,511 | 201 | $23K |
| Meloxicam Generic | 533 | 855 | 119 | $2,609 |
| Prednisone Generic | 368 | 432 | 94 | $1,891 |
| Hydroxychloroquine Sulfate Generic | 330 | 532 | 70 | $11K |
| Alendronate Sodium Generic | 311 | 681 | 88 | $2,756 |
| Enbrel Sureclick Etanercept | 307 | 314 | 36 | $2.3M |
| Allopurinol Generic | 273 | 703 | 74 | $3,454 |
| Gabapentin Generic | 264 | 404 | 47 | $4,121 |
| Nabumetone Generic | 204 | 262 | 49 | $4,361 |
| Humira(Cf) Pen Adalimumab | 202 | 212 | 26 | $1.6M |
| Tramadol Hcl Generic | 173 | 199 | 32 | $2,081 |
| Leflunomide Generic | 156 | 300 | 39 | $10K |
| Diclofenac Sodium Generic | 148 | 180 | 41 | $6,184 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 148 | 148 | 15 | $3,001 |
Brand drugs: - claims; generic drugs: 6,048 claims; opioid claims: 517.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Scott M Halista $44.81 ($44.81 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbott Laboratories with $44.81.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 2 | $44.81 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.